Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Amarillo Biosciences, Inc (OTC BB:AMAR.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Location
800 West Ninth
Amarillo, TX 79101
Phone: (806) 376-1741
Fax: (806) 376-9301
Email: abi@amarbio.com
Employees (last reported count): 6
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 50%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Amarillo Biosciences, Inc. is a development-stage company engaged in developing biologics for the treatment of human and animal diseases. The Company is focusing its research on human health indications for the use of low-dose, orally administered natural human interferon alpha (IFNa), particularly for the treatment of Sjogren's syndrome, fibromyalgia, hepatitis B, hepatitis C and Behcet's disease. The Company owns or licenses 19 United States patents relating to low-dose, oral, natural IFNa. Since 1992, the Company has filed six Investigational New Drug Applications covering indicated uses for low-dose, oral IFNa, including treatment of Sjogren's syndrome and fibromyalgia, with the United States Food and Drug Administration. The Company is seeking regulatory approvals in certain foreign countries to test low-dose, oral IFNa in the treatment of hepatitis B and C.
More from Market Guide: Expanded Business Description

Financial Summary
Amarillo Biosciences, Inc., is a development stage company. The Company develops and markets 19 patents and eight pending applications relating to low dosage oral and non-oral natural interferon alpha used in the treatment of human and animal diseases. For the six months ended 6/30/01, revenues totaled $171 thousand, up from $36 thousand. Net loss fell 85% to $376 thousand. Results reflect orders for anhydrous crystalline maltose, partially offset by higher interest expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Joseph Cummins, Ph.D., 57
Chairman, Pres, CEO and Chief Financial Officer
$150K
Kathleen Kelleher, 51
COO, VP-Bus. Devel.
150K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:AMAR.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Dec-2000
$0.438
Recent Price$0.65 
52-Week High
on 5-Sep-2000
$2.063
Beta0.47 
Daily Volume (3-month avg)2,545 
Daily Volume (10-day avg)0 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-67.5%
52-Week Change
relative to S&P500
-56.4%
Share-Related Items
Market Capitalization$5.11M
Shares Outstanding7.86M
Float3.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.35 
Earnings (ttm)-$0.16 
Earnings (mrq)-$0.02 
Sales (ttm)$0.02 
Cash (mrq)$0.00 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)26.59 
Income Statements
Sales (ttm)$191.0K
EBITDA (ttm)-$1.18M
Income available to common (ttm)-$1.27M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-163.65%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.14 
Debt/EquityN/A 
Total Cash (mrq)$29.0K
Short Interest
As of 8-Oct-1999
Shares Short4,000 
Percent of Float0.1%
Shares Short
(Prior Month)
0 
Short Ratio0.33 
Daily Volume12.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.